Bietz Matthew J, Bloss Cinnamon S, Calvert Scout, Godino Job G, Gregory Judith, Claffey Michael P, Sheehan Jerry, Patrick Kevin
Department of Informatics, Donald Bren School of Information and Computer Sciences, University of California, Irvine, California, USA Center for Wireless and Population Health Systems, Calit2, University of California, San Diego, California, USA.
Center for Wireless and Population Health Systems, Calit2, University of California, San Diego, California, USA Department of Psychiatry, School of Medicine, University of California, San Diego, California, USA Department of Family Medicine and Public Health, School of Medicine, University of California, San Diego, California, USA.
J Am Med Inform Assoc. 2016 Apr;23(e1):e42-8. doi: 10.1093/jamia/ocv118. Epub 2015 Sep 2.
Understand barriers to the use of personal health data (PHD) in research from the perspective of three stakeholder groups: early adopter individuals who track data about their health, researchers who may use PHD as part of their research, and companies that market self-tracking devices, apps or services, and aggregate and manage the data that are generated.
A targeted convenience sample of 465 individuals and 134 researchers completed an extensive online survey. Thirty-five hour-long semi-structured qualitative interviews were conducted with a subset of 11 individuals and 9 researchers, as well as 15 company/key informants.
Challenges to the use of PHD for research were identified in six areas: data ownership; data access for research; privacy; informed consent and ethics; research methods and data quality; and the unpredictable nature of the rapidly evolving ecosystem of devices, apps, and other services that leave "digital footprints." Individuals reported willingness to anonymously share PHD if it would be used to advance research for the good of the public. Researchers were enthusiastic about using PHD for research, but noted barriers related to intellectual property, licensing, and the need for legal agreements with companies. Companies were interested in research but stressed that their first priority was maintaining customer relationships.
Although challenges exist in leveraging PHD for research, there are many opportunities for stakeholder engagement, and experimentation with these data is already taking place. These early examples foreshadow a much larger set of activities with the potential to positively transform how health research is conducted.
从三个利益相关者群体的角度,了解个人健康数据(PHD)在研究中使用的障碍:追踪自身健康数据的早期采用者个体、可能将PHD用作研究一部分的研究人员,以及销售自我追踪设备、应用程序或服务并汇总和管理所生成数据的公司。
对465名个体和134名研究人员进行了有针对性的便利抽样,他们完成了一项广泛的在线调查。对11名个体、9名研究人员以及15名公司/关键信息提供者的子集进行了35次时长为一小时的半结构化定性访谈。
在六个领域确定了使用PHD进行研究的挑战:数据所有权;研究数据获取;隐私;知情同意与伦理;研究方法与数据质量;以及留下“数字足迹”的设备、应用程序和其他服务快速发展的生态系统的不可预测性。个体表示,如果PHD用于推动造福公众的研究,他们愿意匿名分享。研究人员热衷于使用PHD进行研究,但指出了与知识产权、许可相关的障碍,以及与公司签订法律协议的必要性。公司对研究感兴趣,但强调他们的首要任务是维护客户关系。
尽管利用PHD进行研究存在挑战,但利益相关者参与的机会很多,并且已经在对这些数据进行试验。这些早期例子预示着一系列规模更大的活动,有可能积极改变健康研究的开展方式。